BioLineRx Current Ratio 2012-2018 | BLRX

BioLineRx current ratio from 2012 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
BioLineRx Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-09-30 $0.04B $0.01B 7.53
2018-06-30 $0.04B $0.01B 8.02
2018-03-31 $0.05B $0.01B 7.37
2017-12-31 $0.05B $0.01B 7.49
2017-09-30 $0.06B $0.01B 10.11
2017-06-30 $0.05B $0.01B 9.91
2017-03-31 $0.03B $0.01B 6.12
2016-12-31 $0.04B $0.00B 9.86
2016-09-30 $0.04B $0.00B 11.71
2016-06-30 $0.04B $0.00B 15.22
2016-03-31 $0.05B $0.00B 17.93
2015-12-31 $0.05B $0.00B 15.35
2015-09-30 $0.05B $0.00B 14.45
2015-06-30 $0.06B $0.00B 13.42
2015-03-31 $0.06B $0.00B 14.11
2014-12-31 $0.04B $0.00B 12.12
2014-09-30 $0.03B $0.00B 11.47
2014-06-30 $0.03B $0.00B 12.35
2014-03-31 $0.04B $0.00B 11.87
2013-12-31 $0.02B $0.00B 6.17
2013-09-30 $0.02B $0.00B 4.74
2013-06-30 $0.02B $0.01B 4.50
2013-03-31 $0.03B $0.01B 3.89
2012-12-31 $0.02B $0.01B 3.45
2012-09-30 $0.03B $0.01B 3.91
2012-06-30 $0.03B $0.01B 4.85
2012-03-31 $0.04B $0.01B 5.02
2011-12-31 $0.03B $0.01B 4.02
2011-09-30 $0.03B $0.01B 4.63
2011-06-30 $0.04B $0.01B 5.12
2011-03-31 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.049B $0.000B
Bioline RX Ltd. is a biopharmaceutical development company. BioLineRx is dedicated to building a portfolio of products for unmet medical needs or with advantages over currently available therapies. The Company's portfolio consists of clinical stage candidates including BL-1020 for schizophrenia , BL-1040, for treatment of patients following a myocardial infarction, BL-5010 for non-surgical removal of skin lesions, BL-1021 for neuropathic pain and BL-7040 for treating Inflammatory Bowel Disease. In addition, BioLineRx has many products in various pre-clinical development stages for a variety of indications, including central nervous system diseases, oncology, infectious diseases, cardiovascular and autoimmune diseases.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $47.705B 31.73
Takeda Pharmaceutical (TAK) Japan $33.622B 12.44
Grifols (GRFS) Spain $13.132B 15.92
Ionis Pharmaceuticals (IONS) United States $11.141B 34.55
Neurocrine Biosciences (NBIX) United States $8.158B 528.41
Jazz Pharmaceuticals (JAZZ) Ireland $7.761B 11.11
Sage Therapeutics (SAGE) United States $7.440B 0.00
Tilray (TLRY) United States $6.545B 0.00
Catalent (CTLT) United States $6.280B 26.29
Nektar Therapeutics (NKTR) United States $5.829B 9.30
United Therapeutics (UTHR) United States $5.377B 9.14
FibroGen (FGEN) United States $4.759B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $4.340B 23.06
Taro Pharmaceutical Industries (TARO) Israel $4.251B 13.68
PTC Therapeutics (PTCT) United States $2.297B 0.00
Zogenix (ZGNX) United States $2.294B 0.00
Portola Pharmaceuticals (PTLA) United States $2.247B 0.00
Aerie Pharmaceuticals (AERI) United States $2.239B 0.00
Madrigal Pharmaceuticals (MDGL) United States $2.213B 0.00
Ironwood Pharmaceuticals (IRWD) United States $2.182B 0.00
USANA Health Sciences (USNA) United States $2.061B 17.30
Endo (ENDP) Ireland $1.966B 3.03
Enanta Pharmaceuticals (ENTA) United States $1.938B 24.13
Heron Therapeutics (HRTX) United States $1.926B 0.00
Xencor (XNCR) United States $1.807B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.797B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.639B 141.96
Theravance Biopharma (TBPH) Cayman Islands $1.374B 0.00
Corcept Therapeutics (CORT) United States $1.357B 19.72
TherapeuticsMD (TXMD) United States $1.312B 0.00
Esperion Therapeutics (ESPR) United States $1.186B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.134B 0.00
Tricida (TCDA) United States $1.069B 0.00
Radius Health (RDUS) United States $0.884B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.870B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.617B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.598B 0.00
Dermira (DERM) United States $0.577B 0.00
Collegium Pharmaceutical (COLL) United States $0.567B 0.00
GlycoMimetics (GLYC) United States $0.566B 0.00
Odonate Therapeutics (ODT) United States $0.565B 0.00
ArQule (ARQL) United States $0.560B 0.00
Forty Seven (FTSV) United States $0.551B 0.00
ChemoCentryx (CCXI) United States $0.531B 0.00
Akebia Therapeutics (AKBA) United States $0.496B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.495B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.493B 29.09
Siga Technologies (SIGA) United States $0.485B 0.00
KalVista Pharmaceuticals (KALV) United States $0.484B 0.00
Flexion Therapeutics (FLXN) United States $0.476B 0.00
Translate Bio (TBIO) United States $0.448B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.443B 0.00
TCR2 THERAPTCS (TCRR) United States $0.439B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.427B 0.00
Concert Pharmaceuticals (CNCE) United States $0.413B 0.00
OptiNose (OPTN) United States $0.391B 0.00
ImmunoGen (IMGN) United States $0.384B 0.00
Aptorum Group (APM) China $0.380B 0.00
Karyopharm Therapeutics (KPTI) United States $0.354B 0.00
Minerva Neurosciences (NERV) United States $0.324B 0.00
CASI Pharmaceuticals (CASI) United States $0.318B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.316B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.310B 11.50
Lannett Co Inc (LCI) United States $0.302B 2.81
Majesco Entertainment (PTE) United States $0.287B 0.00
Mast Therapeutics (SVRA) United States $0.284B 0.00
Immune Design (IMDZ) United States $0.282B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.278B 0.00
Xeris Pharmaceuticals (XERS) United States $0.271B 0.00
Dova Pharmaceuticals (DOVA) United States $0.264B 0.00
Affimed (AFMD) Germany $0.261B 0.00
HARPOON THERAPT (HARP) United States $0.260B 0.00
Aclaris Therapeutics (ACRS) United States $0.259B 0.00
Calithera Biosciences (CALA) United States $0.258B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.256B 0.00
ElectroCore (ECOR) United States $0.254B 0.00
Opexa Therapeutics (ACER) United States $0.237B 0.00
Tyme Technologies (TYME) United States $0.234B 0.00
Galectin Therapeutics (GALT) United States $0.222B 0.00
MEI Pharma (MEIP) United States $0.220B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.216B 0.00
Jounce Therapeutics (JNCE) United States $0.215B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.214B 0.00
Recro Pharma (REPH) United States $0.211B 0.00
Molecular Templates (MTEM) United States $0.211B 0.00
Aldeyra Therapeutics (ALDX) United States $0.208B 0.00
Ardelyx (ARDX) United States $0.205B 0.00
IMV INC (IMV) Canada $0.202B 0.00
Rafael Holdings (RFL) United States $0.195B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.192B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.191B 0.00
Redhill Biopharma (RDHL) Israel $0.188B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.188B 0.00
Aratana Therapeutics (PETX) United States $0.188B 0.00
Ocular Therapeutix (OCUL) United States $0.178B 0.00
Nature's Sunshine Products (NATR) United States $0.176B 182.40
Aquestive Therapeutics (AQST) United States $0.174B 0.00
Neos Therapeutics (NEOS) United States $0.166B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.164B 0.00
Neon Therapeutics (NTGN) United States $0.156B 0.00
AgeX Therapeutics (AGE) United States $0.150B 0.00
ProNAi Therapeutics (SRRA) Canada $0.142B 0.00
MediWound (MDWD) Israel $0.140B 0.00
China SXT Pharmaceuticals (SXTC) China $0.138B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.137B 0.00
Cardiome Pharma (CORV) Canada $0.121B 0.00
Champions Oncology (CSBR) United States $0.121B 0.00
DURECT (DRRX) United States $0.119B 0.00
Zafgen (ZFGN) United States $0.112B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.111B 0.00
Adherex Technologies (FENC) United States $0.107B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.107B 0.00
Iterum Therapeutics (ITRM) Ireland $0.106B 0.00
Infinity Pharmaceuticals (INFI) United States $0.098B 0.00
Nivalis Therapeutics (ALPN) United States $0.094B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.091B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.091B 0.00
Otonomy (OTIC) United States $0.089B 0.00
Avenue Therapeutics (ATXI) United States $0.088B 0.00
Natural Alternatives (NAII) United States $0.084B 8.24
Genocea Biosciences (GNCA) United States $0.081B 0.00
SCYNEXIS (SCYX) United States $0.079B 0.00
India Globalization Capital (IGC) United States $0.078B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.070B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.067B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.065B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.061B 0.00
Forward Pharma (FWP) Denmark $0.059B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.058B 0.00
CTI BioPharma (CTIC) United States $0.057B 0.00
KemPharm (KMPH) United States $0.054B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.054B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.052B 0.00
Lipocine (LPCN) United States $0.052B 0.00
Capnia (SLNO) United States $0.050B 0.00
Melinta Therapeutics (MLNT) United States $0.048B 0.00
Bio-Path Holdings (BPTH) United States $0.046B 0.00
Mannatechorporated (MTEX) United States $0.044B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.041B 0.00
NOVAN INC (NOVN) United States $0.037B 0.00
ProPhase Labs (PRPH) United States $0.037B 0.00
ContraFect (CFRX) United States $0.037B 0.00
HANCOCK JAFFE (HJLI) United States $0.035B 0.00
Achaogen (AKAO) United States $0.035B 0.00
Heat Biologics (HTBX) United States $0.030B 0.00
PharmAthene (ALT) United States $0.027B 0.00
Can-Fite Biopharma (CANF) Israel $0.027B 0.00
Citius Pharmaceuticals (CTXR) United States $0.026B 0.00
Shineco (TYHT) China $0.026B 4.42
Summit Therapeutics (SMMT) United Kingdom $0.026B 0.00
Onconova Therapeutics (ONTX) United States $0.026B 0.00
IsoRay (ISR) United States $0.025B 0.00
Biomerica (BMRA) United States $0.025B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.023B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.022B 0.00
ESSA Pharma (EPIX) Canada $0.021B 0.00
Jaguar Animal Health (JAGX) United States $0.021B 0.00
Pain Therapeutics (PTIE) United States $0.021B 0.00
NanoViricides (NNVC) United States $0.021B 0.00
Cyanotech (CYAN) United States $0.020B 0.00
Achieve Life Sciences (ACHV) United States $0.020B 0.00
Xenetic Biosciences (XBIO) United States $0.018B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.018B 0.00
VAXART, INC (VXRT) United States $0.018B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.018B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.015B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.013B 0.00
PRECISION THERAPEUTICS INC (AIPT) United States $0.012B 0.00
Regulus Therapeutics (RGLS) United States $0.012B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.012B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.012B 0.00
Midatech Pharma (MTP) United Kingdom $0.011B 0.00
Trillium Therapeutics (TRIL) Canada $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.008B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.007B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.006B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.000B 0.00
Bio Blast Pharma (ORPN) Israel $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00